Carcinoma, Non Small Cell Lung Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Durvalumab + SoC chemotherapy
  • Placebo + SoC chemotherapy
  • Birmingham, Alabama
  • +278 more
2021-11-18
Nov 18, 2021
H
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Thoracic Radiotherapy
  • +3 more
  • Tampa, Florida
  • +2 more
2021-11-16
Nov 16, 2021
E
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Indianapolis, Indiana
  • +7 more
2021-11-15
Nov 15, 2021
A
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Atlanta, Georgia
  • +6 more
2021-11-15
Nov 15, 2021
N
Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +5 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
2021-11-08
Nov 8, 2021
N
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-11-11
Nov 11, 2021
S
Recruiting
  • Colorectal Neoplasms
  • +3 more
  • tisotumab vedotin
  • Sacramento, California
  • +35 more
2021-11-05
Nov 5, 2021
F
Recruiting
  • Lung Diseases
  • +6 more
  • Elche, Alicante, Spain
  • +21 more
2021-11-09
Nov 9, 2021
N
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Whittier, California
  • +9 more
2021-11-09
Nov 9, 2021
C
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Bone Metastases
  • Denosumab-nivolumab combination
  • Aix-en-Provence, France
  • +27 more
2021-11-09
Nov 9, 2021